Inventor
LEVEILLARD THIERRY
FR16 patents
⚠️ This page may combine multiple inventors who share the name “LEVEILLARD THIERRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LEVEILLARD THIERRY
7 patentsUS8518695B2Aug 27, 2013
Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2
LEVEILLARD THIERRY13 citations91
US8394756B2Mar 12, 2013
Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells
LEVEILLARD THIERRY14 citations91
US8114849B2Feb 14, 2012
Retinal dystrophy-associated protein and uses thereof
LEVEILLARD THIERRY15 citations91
US8071745B2Dec 6, 2011
Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same
LEVEILLARD THIERRY14 citations91
US8779093B2Jul 15, 2014
Neuronal viability factor and use thereof
LEVEILLARD THIERRY5 citations69
US9575075B2Feb 21, 2017
Methods for treating cone dystrophy with neuronal viability factor, RDCVF2
LEVEILLARD THIERRY2 citations65
US8193153B2Jun 5, 2012
Trophic factor for the treatment of retinal degenerative diseases
LEVEILLARD THIERRY5 citations58
INST NAT SANTE RECH MED
5 patentsUS10668129B2Jun 2, 2020
Synergistic combination of neuronal viability factors and uses thereof
INST NAT SANTE RECH MED2 citations67
US10004780B2Jun 26, 2018
Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)
INST NAT SANTE RECH MED2 citations66
US11428698B2Aug 30, 2022
Neuronal viability factor and use thereof in Alzheimer's disease
INST NAT SANTE RECH MED1 citations57
US11723988B2Aug 15, 2023
Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector
INST NAT SANTE RECH MED1 citations53
US10857239B2Dec 8, 2020
Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries
INST NAT SANTE RECH MED0 citations45